Healthcare Hedge Fund Palo Alto Up 26% In Q2

Sep 17 2012 | 1:37pm ET

A healthcare hedge fund had a second quarter it won't soon forget, jumping more than a quarter on the period.

Palo Alto Investors rose 26.2% between April and June, Insider Monkey reports. The surge is thanks in no small part to Palo Alto's largest holding, Onyx Pharmaceuticals, which makes up almost 17% of the hedge fund's portfolio and which is up 74.5% this year.

Palo Alto also profited from its stakes in Cyberonics Inc.


In Depth

Kettera Q&A: The Advantages of Alternative Investment Platforms

Oct 28 2016 | 5:52pm ET

The past several years have seen a distinct push towards easier and cheaper access...

Lifestyle

Midtown's Plaza District Fades As Manhattan Office Landscape Shifts

Nov 22 2016 | 6:32pm ET

Lower leasing costs, more efficient office space and the hope of projecting an image...

Guest Contributor

Nowhere to Hide: Why the Future of Asset Management Depends on Innovation

Nov 15 2016 | 6:55pm ET

Information technology has reshaped the asset management industry’s periphery,...

 

From the current issue of

Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR